title: The antitumorigenic trifecta.
abstract: The laboratory of Judah Folkman identified the potent endogenous antiangiogenic protein angiostatin in 1994.(1) In this issue of Blood, Lee and colleagues propose 2 new mechanisms of action for angiostatin that may represent promising targets for new cancer therapeutics.(2).
authors.affiliation: Duke University.
authors.forename: Yvonne M
authors.initials: YM
authors.lastname: Mowery
authors.forename: Salvatore V
authors.initials: SV
authors.lastname: Pizzo